The UW School of Pharmacy’s Department of Pharmaceutics is excited to introduce and welcome two new faculty members: Dr. Samuel Arnold and Dr. Shijie Cao. Dr. Arnold will begin his role as assistant professor January 1, 2023. Dr. Cao will join the department as assistant professor June 1, 2023.
After receiving his PhD from the Department of Bioengineering at the UW, Dr. Cao joined the laboratories of Dr. Jeffrey Hubbel and Dr. Cathryn Nagler at the University of Chicago’s Pritzker School of Molecular Engineering as a post-doctoral fellow studying polymeric drug delivery platforms and immunoengineering.
Dr. Cao’s research goal is to leverage drug delivery and immunoengineering approaches to control dysregulated immune responses and develop innovative and translatable tools to prevent and treat such infectious diseases and immunological disorders as allergies, autoimmune diseases, and inflammation. His research program will focus on microbiome pharmaceutics, utilizing biomaterial and pharmaceutical strategies to design and modify microbiome-based therapeutics.
Dr. Arnold, who received his PhD from the UWSOP’s Department of Pharmaceutics, conducted post- doctoral studies in the Division of Allergy and Infectious Disease in the UW School of Medicine and was promoted to Assistant Professor of Medicine. His research program focuses on in vitro and in vivo methods of infectious diseases, as well as innovative pharmacokinetic modeling approaches to determine drug disposition and pharmacologic effects in the gastrointestinal tract. His program will also focus on drug development for Shigellosis, impact of diarrhea on drug disposition, and PK-PD analysis. Upon joining the Department of Pharmaceutics, Dr. Arnold will also become the director of the Pharmacokinetics and Modeling laboratory in the Department of Pharmaceutics.
We look forward to welcoming both Dr. Arnold and Dr. Cao to the Department and the School of Pharmacy.